Comorbidities | Univariate analysis | Multivariate logistic regression | ||||||
---|---|---|---|---|---|---|---|---|
No transfusion | Transfusion | P | OR | 95% CI | P | |||
Preoperative comorbidities | Â | Â | Â | Â | Â | Â | ||
 | Acquired immune deficiency syndrome | 120 (0.1%) | 24 (0.2%) | 0.183 | 1.208 | 0.767–1.903 | 0.416 | |
 | Alcohol abuse | 1283 (1.3%) | 290 (1.9%) | <0.001 | 1.078 | 0.940–1.237 | 0.284 | |
 | Iron deficient anemia | 8283(8.3%) | 3277 (22.0%) | <0.001 | 2.433 | 2.320–2.551 | <0.001 | |
 | Rheumatoid arthritis/collagen vascular diseases | 5725 (5.7%) | 1262 (8.5%) | <0.001 | 1.287 | 1.204–1.376 | <0.001 | |
 | Chronic blood loss anemia | 1008 (1.0%) | 439 (2.9%) | <0.001 | 2.722 | 2.418–3.063 | <0.001 | |
 | Congestive heart failure | 5042 (5.0%) | 1619 (10.9%) | <0.001 | 1.402 | 1.312–1.497 | <0.001 | |
 | Chronic pulmonary disease | 18,961 (18.9%) | 3113 (20.9%) | <0.001 | 0.945 | 0.903–0.989 | 0.015 | |
 | Coagulopathy | 2798 (2.8%) | 1165 (7.8%) | <0.001 | 1.895 | 1.754–2.047 | <0.001 | |
 | Depression | 17,718 (17.7%) | 2892 (19.4%) | <0.001 | 0.991 | 9.45–1.038 | 0.693 | |
 | Diabetes, uncomplicated | 19,239 (19.2%) | 3511(23.6%) | <0.001 | 1.151 | 1.100-1.203 | <0.001 | |
 | Diabetes with chronic complications | 5747 (5.7%) | 1263 (8.5%) | <0.001 | 1.010 | 0.941–1.085 | 0.078 | |
 | Drug abuse | 1554 (1.6%) | 311 (2.1%) | <0.001 | 1.079 | 0.948–1.229 | 0.249 | |
 | Hypertension | 67,080 (67.0%) | 10,927 (73.3%) | <0.001 | 0.981 | 0.936–1.028 | 0.415 | |
 | Hypothyroidism | 16,547 (16.5%) | 2870 (19.3%) | <0.001 | 1.035 | 0.988–1.085 | 0.144 | |
 | Liver disease | 2448 (2.4%) | 583 (3.9%) | <0.001 | 1.033 | 0.933–1.142 | 0.534 | |
 | Lymphoma | 292 (0.3%) | 118 (0.8%) | <0.001 | 1.998 | 1.593–2.506 | <0.001 | |
 | Fluid and electrolyte disorders | 10,306 (10.3%) | 3555 (23.9%) | <0.001 | 1.843 | 1.758–1.931 | <0.001 | |
 | Metastatic cancer | 156 (0.2%) | 73 (0.5%) | <0.001 | 1.986 | 1.473–2.678 | <0.001 | |
 | Other neurological disorders | 3877 (3.9%) | 1061 (7.1%) | <0.001 | 1.348 | 1.252–1.452 | <0.001 | |
 | Obesity | 28,611 (28.6%) | 4164 (27.9%) | 1.22 | 0.809 | 0.776–0.843 | <0.001 | |
 | Paralysis | 307 (0.3%) | 107 (0.7%) | <0.001 | 1.715 | 1.358–2.165 | <0.001 | |
 | Peripheral vascular disorders | 2580 (2.6%) | 703 (4.7%) | <0.001 | 1.311 | 1.197–1.435 | <0.001 | |
 | Psychoses | 3435 (3.4%) | 691 (2.4%) | <0.001 | 1.153 | 1.056–1.259 | 0.002 | |
 | Pulmonary circulation disorders | 1374 (1.4%) | 500 (3.4%) | <0.001 | 1.364 | 1.218–1.528 | <0.001 | |
 | Renal failure | 7465 (7.5%) | 2344 (15.7%) | <0.001 | 1.454 | 1.374–1.539 | <0.001 | |
 | Solid tumor without metastasis | 638 (0.6%) | 158 (1.1%) | <0.001 | 1.228 | 1.020–1.479 | 0.003 | |
 | Peptic ulcer disease excluding bleeding | 192 (0.2%) | 27 (0.2%) | 0.785 | 0.84 | 0.528–1.222 | 0.307 | |
 | Valvular disease | 3666 (3.7%) | 959 (6.4%) | <0.001 | 1.239 | 1.145–1.341 | <0.001 | |
 | Weight loss | 1267 (1.3%) | 664 (4.5%) | <0.001 | 1.955 | 1.763–2.167 | <0.001 |